1. Background risk should be taken into account when reporting vaccine effectiveness. Issue 7 (24th January 2022) Authors: Zahradka, Ivan; Petr, Vojtech; Magicova, Maria; Viklicky, Ondrej Journal: American journal of transplantation Issue: Volume 22:Issue 7(2022) Page Start: 1927 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Determinants of Immune Response to Anti–SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients: A Prospective Cohort Study. Issue 4 (6th January 2022) Authors: Magicova, Maria; Zahradka, Ivan; Fialova, Martina; Neskudla, Tomas; Gurka, Jiri; Modos, Istvan; Hojny, Michal; Raska, Petr; Smejkal, Petr; Striz, Ilja; Viklicky, Ondrej Journal: Transplantation Issue: Volume 106:Issue 4(2022) Page Start: 842 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. First Booster of SARS-COV-2 mRNA Vaccine Is Not Associated With Alloimmunization and Subclinical Injury of Kidney Allograft. Issue 2 (29th October 2022) Authors: Petr, Vojtech; Zahradka, Ivan; Modos, Istvan; Roder, Matej; Prewett, Adam; Fialova, Martina; Machkova, Jana; Hruba, Petra; Magicova, Maria; Slavcev, Antonij; Striz, Ilja; Viklicky, Ondrej Journal: Transplantation Issue: Volume 107:Issue 2(2023) Page Start: e62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Humoral response to SARS‐CoV‐2 is well preserved and symptom dependent in kidney transplant recipients. Issue 12 (19th July 2021) Authors: Magicova, Maria; Fialova, Martina; Zahradka, Ivan; Rajnochova‐Bloudickova, Silvie; Hackajlo, David; Raska, Petr; Striz, Ilja; Viklicky, Ondrej Journal: American journal of transplantation Issue: Volume 21:Issue 12(2021) Page Start: 3926 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗